Galectin-3 (gal-3), a member of the B-galactoside-binding proteins family, was identified as a binding partner of Bcatenin. Analysis of the human gal-3 sequence reveled a structural similarity to B-catenin as it also contains the consensus sequence (S 92 XXXS 96 ) for glycogen synthase kinase-3B (GSK-3B) phosphorylation and can serve as its substrate. In addition, Axin, a regulator protein of Wnt that complexes with B-catenin, also binds gal-3 using the same sequence motif identified here by a deletion mutant analysis. The data presented here give credence to the suggestion that gal-3 is a key regulator in the Wnt/B-catenin signaling pathway and highlight the functional similarities between gal-3 and Bcatenin. 
Introduction
Galectins are a family of carbohydrate-binding proteins characterized by conserved amino acid sequences of their carbohydratebinding domains and affinity for h-galactoside-containing glycoconjugates (1) . Galectin-3 (gal-3) exhibits pleiotropic biological functions and has been implicated in cell growth, differentiation, apoptosis, adhesion, malignant transformation, and RNA processing (1) (2) (3) (4) .
Previously, we have reported that gal-3 overexpression regulates the expression levels of cell cycle targets of Wnt pathway, like cyclin D 1 and c-myc (5-7), and found that gal-3 is a novel binding partner of h-catenin and is phosphorylated, like h-catenin, by casein kinase I (CKI; ref. [7] [8] [9] . h-catenin is phosphorylated by a dual kinase system of CKIa and glycogen synthase kinase-3h (GSK-3h) in a complex containing adenomatous polyposis coli and axin, targeting h-catenin for ubiquitination and degradation (10) (11) (12) (13) (14) . Gene mutations in APC, axin, or h-catenin augment phosphorylation, which, in turn, leads to its accumulation in the nucleus, resulting in activation of transcription of Wnt-target genes (11, 14) . Because the nuclear import-export of gal-3, like that of h-catenin, is phosphorylation dependent (9), we questioned whether gal-3 may also be phosphorylated by a similar dual kinase system. A search of the human gal-3 protein amino acid sequence revealed that in addition to a CKI phosphorylation site (Ser 6 ; ref. 9) , it also contains the GSK-3h phosphorylation consensus sequence (S 92 XXXS 96 ). This prompted us to question whether gal-3 is phosphorylated by GSK3h and whether gal-3 will bind Axin in a phosphorylationdependent manner.
Materials and Methods
Cells and reagents. The origin and the culture conditions of the human breast cancer cell line BT549, the Gal-3-transfected cell clones (BT549-Gal), and the control transfectants (BT549-vCTR) were as described (15, 16) . TIB166, monoclonal rat anti-gal-3, was purchased from American Type Culture Collection (Manassas, VA). hL31, anti-gal-3 antibody, was obtained as described (7) . Anti-HA antibody was purchased from Cell Signaling Technology, Inc. (Beverly, MA) and anti-phospho-serine antibody from Sigma (St. Louis, MO). Recombinant GSK3h was purchased from New England BioLabs, Inc. (Beverly, MA).
Plasmid construction. pGEX-2T/rat Axin (rAxin; 298-832), pGEX-2T/ rAxin (298-506), pGEX-2T/rAxin (1-529), pGEX-2T/rAxin (508-732), and pGEX-2T/rAxin (713-832) were described elsewhere (7). pcDNA3.1+/Zeo-HA-Axin was kindly provided by Dr. Shuichi Kusano (St. Marianna University School of Medicine, Kawasaki, Japan). pGEX-6P-2/gal-3 and gal-3 deletion mutants were as described (7) . Production of recombinant glutathione S-transferase (GST) fusion proteins were produced and purified according to the manufacturer's instruction (Amersham Biosciences, Piscataway, NJ).
Immunoprecipitation. To determine whether gal-3 forms a complex with axin, BT549-Gal cells were transiently transfected in a 100-mmdiameter dish with pcDNA 3.1+/Zeo-HA-Axin using LipofectAMINE 2000 (Invitrogen, Carlsbad, CA). Twenty-four hours after transfection, cells were lysed in 800 AL ice-cold lysis buffer (procedural and technical detail as in ref. 7) . The supernatant (200 Ag protein) were immunoprecipitated with anti-gal-3 or anti-HA antibodies for 60 minutes at 4jC. Protein separations and identification were as described (7) .
Mapping the Axin-galectin-3 binding region. Various deletion mutants of GST-h-rAxin (each at 250 nmol/L) were incubated with 250 nmol/L gal-3 ( full length) for 1 hour at 4jC in 50 AL reaction mixture [20 mmol/L Tris-HCl (pH 7.5) and 1 mmol/L DTT]. GST-Axin deletion mutants were precipitated with glutathione-Sepharose 4B, and then the precipitates were probed with anti-gal-3 antibody. To examine the region of gal-3 that binds to rAxin, various deletion mutants of gal-3 (250 nmol/L each) were incubated with 250 nmol/L of GST-rAxin (298-832) for 1 hour at 4jC in 50 AL reaction mixture. GST-rAxin deletion mutants were precipitated with glutathione-Sepharose 4B and probed with the anti-gal-3 antibody.
In vitro kinase assay. To examine whether gal-3 is phosphorylated by GSK3h, in vitro kinase assay was done. Purified gal-3 (1 Ag protein) was incubated in a kinase buffer containing 10 ACi [g-32 P]ATP with indicated units of GSK-3h in the presence or absence of Axin (indicated amount). LiCl (30 mmol/L), a specific GSK-3h inhibitor, was used to establish specificity. The reaction was stopped by boiling, followed by SDS-PAGE and autoradiography (9) .
Results and Discussions
Axin-galectin-3 interaction. Previously, it was reported that the h-catenin-Axin association promotes h-catenin phosphorylation by GSK3h (12, 13), whereas we found that gal-3 is a binding partner of h-catenin (7). Because human gal-3 contains the consensus sequence motif of GSK3h phosphorylation (S 92 XXXS 96 ), we questioned whether gal-3 could bind Axin and be phosphorylated by GSK-3h. Thus, BT549-Gal cells were transiently transfected with HAAxin cDNA, lysed, and immunoprecipitated with either anti-HA ( Fig. 1A, right ; B, left) or anti-gal-3 antibodies (Fig. 1A, left ; B, right) and Western blotted with the reciprocal antibodies ( Fig. 1A and B,  bottom) . The results show that Axin coprecipitated with gal-3 and vice versa, suggesting that the two are complexed in vivo. Next, we confirmed that Axin-gal-3 are indeed colocalized in vivo by immunofluorescence (Fig. 1C) by using confocal microscopy analysis of BT549 (gal-3 null; Fig. 1C a, b , and c) parental and BT549-Gal (Fig. 1C d, e , and f ) cells transiently transfected with HAAxin (Fig. 1C) . In cells expressing both Axin and gal-3, colocalization of the two proteins is readily observed (Fig. 1C, f ) . Subsequently, we A, the scheme of the deletion mutant of rAxin. B, GST-rAxin (1-229), GST-rAxin (1-529), GST-rAxin (298-506), GST-rAxin (508-832), GST-rAxin (298-832), and GST-rAxin (713-832) were subjected to SDS-PAGE followed by Coomassie Brilliant Blue staining. The common bands at f25 kDa means separated GST. C, various deletion mutants of GST-h-rAxin (each at 250 nmol/L) were incubated with 250 nmol/L gal-3 (full length) for 1 hour at 4jC in 50 AL reaction mixture as described in Materials and Methods. GST-rAxin deletion mutants were precipitated with glutathione-Sepharose 4B. The precipitates were then subjected to SDS-PAGE and probed with TIB166. D, the scheme of the deletion mutants of gal-3. Ser 6 is the phosphorylation site of casein kinase I. Matrix metalloproteinase has been reported to cleave gal-3 between residues 62 and 63. E, purified deletion mutants of gal-3 were subjected to SDS-PAGE followed by Coomassie brilliant blue staining. F, the deletion mutants of gal-3 was incubated with GST-rAxin (298-832) in the reaction mixture. The mixture was precipitated with glutathione-Sepharose 4B and then the precipitates were subjected to SDS-PAGE and probed with anti-gal-3 antibody, hL31. Figure 3 . Phosphorylation of gal-3 by GSK-3h. A, gal-3 was subjected to in vitro kinase assay in the presence or absence of GSK3h, rAxin, and LiCl as described in Materials and Methods. The reaction mixtures containing 10 ACi [g-32 P]ATP were subjected to SDS-PAGE. The effect of addition of 30 mmol/L LiCl, a specific inhibitor of GSK3h, was also examined. B, recombinant gal-3 was incubated for 30 minutes with the indicated amounts of GSK-3h in the kinase reaction mixture. The reaction mixtures were subjected to the same assay. C, recombinant gal-3 was incubated with 50 units GSK3h for the indicated periods. The reaction mixtures were subjected to SDS-PAGE. Data are representative of three independent sets of experiments.
have constructed and expressed deletion mutants of Axin ( Fig. 2A and B) and gal-3 ( Fig. 2D and E) to assist in determining the Axin-gal-3 interacting motifs necessary for their interaction. The Axin mutant peptides were purified as GST fusion proteins and gal-3 was precipitated with GST-Axin (1-528), GST-Axin (298-508), and GSTAxin (298-832) peptides but not with GST-Axin (1-229), GST-Axin (508-832), or GST-Axin (713-832) peptides (Fig. 2C) . In the reciprocal experiments (Fig. 2F) , only gal-3 ( full length) and gal-3 (63-250) peptides were recognized by GST-Axin (298-508) peptide. Thus, we have concluded that the internal domain of Axin interacts with the COOH terminus of gal-3, encompassing amino acid residues 298-508 and 143-250, respectively.
GSK-3B phosphorylates galectin-3. Because the human gal-3 contains a GSK-3h phosphorylation consensus sequence (S 92 XXXS 96 ), we first questioned its substrate suitability utilizing an in vitro kinase assay. Following incubation of gal-3 with or without GSK-3h in a reaction mixture containing [g-32 P]ATP, we found that gal-3 was phosphorylated by GSK-3h and that the phosphorylation was specifically inhibited by a GSK-3h inhibitor, e.g., LiCl (Fig. 3A) . Similar to h-catenin whereby Axin enhances its GSK-3h-dependent phosphorylation (10-13), Axin promoted the GSK-3h-dependent phosphorylation of gal-3 (Fig. 3A) . Of note, the phosphorylation of gal-3 by GSK-3h was specific in a time-and dosedependent manner ( Fig. 3B and C) . The above results and the previous data (7, 9 ) prompted the proposed model (Fig. 4) that revises the Wnt/h-catenin signaling pathway to include gal-3.
It was surprising to find that both gal-3 and h-catenin are substrates of CKI and GSK-3h. As for gal-3, phosphorylation of Ser 6 by CKI serves as a molecular switch for the sugar binding (17) and regulation of nuclear export (9) ; unlike the phosphorylation of h-catenin by CK1a and GSK3h that promotes its proteosomal degradation, the consequence of GSK-3h gal-3 phosphorylation mediated by Axin is yet to be determined. In addition, we will need to resolve whether the phosphorylation of gal-3 affects the status of phosphorylation of hcatenin or vice versa and to establish whether gal-3 engages/mediates/ inhibits the ubiquitination/signaling of h-catenin.
